Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
1,618
+146
+10% +$50K 0.06% 129
2026
Q1
$518K Sell
1,472
-64
-4% -$22.8K 0.05% 135
2025
Q4
$503K Buy
+1,536
New +$487K 0.06% 129

Other funds holding AMGN

Legacy Edge Advisors's AMGN Position: Q2 2026 in Review

Legacy Edge Advisors increased its Amgen (AMGN) stake by 9.9% in Q2 2026, buying an estimated $50K and bringing the position to 1,618 shares worth $452K. The position accounts for 0.06% of the portfolio, ranked #129.

Legacy Edge Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $518K in Q1 2026. 2,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Legacy Edge Advisors held 1,618 shares of Amgen worth $452K as of Q2 2026.
  • Legacy Edge Advisors bought 146 Amgen shares in Q2 2026, an estimated $50K.
  • Amgen made up 0.06% of Legacy Edge Advisors's portfolio in Q2 2026, its #129 holding.
  • Legacy Edge Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Legacy Edge Advisors's Amgen position peaked at $518K in Q1 2026.
  • 2,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.